Abstract
Abstract
Monoclonal antibody therapeutics to treat coronavirus disease (COVID-19) have been authorized by the US Food and Drug Administration under Emergency Use Authorization (EUA). Many barriers exist when deploying a novel therapeutic during an ongoing pandemic, and it is critical to assess the needs of incorporating monoclonal antibody infusions into pandemic response activities. We examined the monoclonal antibody infusion site process during the COVID-19 pandemic and conducted a descriptive analysis using data from 3 sites at medical centers in the United States supported by the National Disaster Medical System. Monoclonal antibody implementation success factors included engagement with local medical providers, therapy batch preparation, placing the infusion center in proximity to emergency services, and creating procedures resilient to EUA changes. Infusion process challenges included confirming patient severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positivity, strained staff, scheduling, and pharmacy coordination. Infusion sites are effective when integrated into pre-existing pandemic response ecosystems and can be implemented with limited staff and physical resources.
Publisher
Cambridge University Press (CUP)
Subject
Public Health, Environmental and Occupational Health
Reference20 articles.
1. Staffing and capacity planning for SARS-CoV-2 monoclonal antibody infusion facilities: a performance estimation calculator based on discrete-event simulations;Caglayan;Front Public Health,2022
2. The Equitable Distribution of COVID-19 Therapeutics and Vaccines
3. Microneedle for transdermal drug delivery: current trends and fabrication
4. Administration of Monoclonal Antibody for COVID-19 in Patient Homes
5. 3. COVID-19 Treatment Guidelines, Anti-SARS-CoV-2 Monoclonal Antibodies . National Institutes of Health (NIH). Published 2021. Accessed April 1, 2021. https://www.covid19treatmentguidelines.nih.gov/therapies/anti-sars-cov-2-antibody-products/anti-sars-cov-2-monoclonal-antibodies/
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献